Loading...
[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop]. / Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens
Zimmermann, Ruth Külper-Schiek, Wiebe Steffen, Gyde Gillesberg Lassen, Sofie Bremer, Viviane Dudareva, Sandra die Hepatitis-Monitoring-Arbeitsgruppe
Zimmermann, Ruth
Külper-Schiek, Wiebe
Steffen, Gyde
Gillesberg Lassen, Sofie
Bremer, Viviane
Dudareva, Sandra
die Hepatitis-Monitoring-Arbeitsgruppe
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-12-16
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 488.03 KB
Other Titles
/ Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens (Article in German)
Abstract
Background: In 2016, the World Health Organization (WHO) released a strategy to eliminate hepatitis B, C, and D and defined indicators to monitor the progress. The Robert Koch Institute organized an interdisciplinary working meeting in 2019 to identify data sources and gaps. Objectives: The objectives were to network, to create an overview of the data sources available in Germany on hepatitis B and C, and to discuss how to construct indicators. Materials and methods: We extracted the WHO indicators relevant for Germany and determined how they can be constructed on the basis of available data. Stakeholders from public health services, clinics, laboratories, health insurance companies, research institutes, data holders, and registries attended a workshop and discussed methods of constructing the indicators for which data are lacking. Data sources and data were evaluated and prioritized with regard to their quality and completeness. Results: Indicators on prevalence, incidence, prevention, testing and diagnosis, treatment, cure, burden of sequelae, and mortality for the general population can be constructed using secondary data such as diagnosis, health service, and registry data, data from laboratories and hospitals as well as population-based studies. Data sources for vulnerable groups are limited to studies among drug users, men who have sex with men, and about HIV coinfected patients. Data for migrants, prisoners, and sex workers are largely lacking as well as data on burden of disease from chronic viral hepatitis in the general population. Conclusions: We identified data sources, their limitations, and methods for construction for all selected indicators. The next step is to convert the ideas developed into concrete projects with individual stakeholders.
Citation
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Jan;64(1):77-90. German. doi: 10.1007/s00103-020-03260-2. Epub 2020 Dec 16.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
de
Description
Series/Report no.
ISSN
EISSN
1437-1588
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International